Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3070-3080
Author(s):
Jiezhong Chen, Kong-Nan Zhao, Rui Li, Renfu Shao and Chen Chen
HIF-1 Signaling in Drug Resistance to Chemotherapy
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3021-3028
Author(s):
N.A. Warfel and W.S. El-Deiry
Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3029-3041
Author(s):
Hongping Xia and Kam M. Hui
Targeting Platinum Resistant Disease in Ovarian Cancer
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3009-3020
Author(s):
S.L. Morgan, J.E. Medina, M.M. Taylor and D.M. Dinulescu
ent-Kaurane Diterpenoids from Croton tonkinensis Induce Apoptosis in Colorectal Cancer Cells through the Phosphorylation of JNK Mediated by Reactive Oxygen Species and Dual-Specificity JNK Kinase MKK4
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
1051-1061
Author(s):
Phuong Thien Thuong, Nguyen Minh Khoi, Saho Ohta, Shinichiro Shiota, Hironori Kanta, Kenji Takeuchi and Fumiaki Ito
Betulinic Acid as a Potent and Complex Antitumor Phytochemical: A Minireview
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
936-945
Author(s):
Dorina Gheorgheosu, Oana Duicu, Cristina Dehelean, Codruta Soica and Danina Muntean
High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2917-2926
Author(s):
N. Katsiki, V.G. Athyros, A. Karagiannis and D.P. Mikhailidis
Patent Selections
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
8
Page:
146-151
Author(s):
MicroRNA Therapeutics: The Emerging Anticancer Strategies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
9
Page:
286-296
Author(s):
Chakresh K. Jain, Aman Gupta, Nidhi Dogra, Vipul S. Kumar, Gulshan Wadhwa and Sanjeev K. Sharma
Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
9
Page:
354-371
Author(s):
Jelena Krstic, Irina Maslovaric and Juan F. Santibanez